The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
December 9th 2024
In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Association’s recently newly-released 2024 State of Lung Cancer report.
Todd Villines: Learning Valuable Lessons while Serving Overseas
One of the biggest differences between military and civilian medicine is the very real chance of being deployed to a forward military unit from a stateside appointment. Lessons from those experiences can shape a doctor's practice back in their home country.
Howard Schatz: Moving from the Operating Room to the Dark Room
It was supposed to be just a one year sabbatical for Howard Schatz to take a break from his work as a retina specialist and enjoy what had become a growing hobby of photography. More than two decades later Schatz said he misses some parts of practice but is greatly enjoying what has become a second career.
Microbe Balance in Infant Airways May Predict Bronchopulmonary Dysplasia, Future Lung Diseases
Because those who experience BPD very early in life are believed to be at a higher risk of decreased lung function and other chronic breathing issues like apnea and asthma, the study of microbial balance in infant airways could provide doctors with important predictive information.
“I felt like a completely different person": New Asthma Pill Impresses in Early Study
Moderate-to-severe asthmatics typically hover around 5% sputum eosophinal, with non-asthmatics under 1%. After the study, the average participant in the fevipiprant group saw a reduction from 5.4% to about 1.1%.
Analysis revealed that adding mepolizumab resulted in a cost-effectiveness ratio of $385,546 per quality-adjusted life-year, or QALY; the price would need to be discounted by more than 70% to reach $100,000 per QALY, a common threshold at which insurers are willing to pay.
Hospital Admission an Opportunity to Evaluate, Educate about Asthma's Comorbidity Potential
Hospital admission allows clinicians to optimize asthma management even when asthma patients have no breathing complaints or abnormal chest exam findings. Although the illness that prompted admission must be treated quickly, asthma care can also be discussed with patients.
Study Finds Key Outcome Predictors For Reducing Asthma Therapy
Stepping down asthma therapy is often avoided because of fear of exacerbation, but a better understanding of factors that predict step-down outcomes could encourage clinicians to wean patients off medications appropriately.
David Nash: Helping Doctors Transition to Population Health
For many veteran doctors there may be a leaning toward staying the course that has guided them through their careers. As times change there have been signs that doctors must also adapt to the changing medical landscape.
David Nash from Thomas Jefferson University: An Introduction to Population Health at the ACC
At the American College of Cardiology's annual meeting in Chicago the opening discussion in front of thousands of the top doctors across the country focused on a developing specialty aimed at improving patient health in non-traditional ways.
How Can Doctors Better Care for COPD Patients?
University of Michigan researchers reviewed previous studies on COPD care and interviewed other contacts in the field to determine major industry challenges facing COPD patients and ways in which doctors and healthcare providers can better assist them.
Motivational Health Coaching Reduces COPD Hospital Readmissions
A new study suggests that personal, motivational coaching may reduce instances of e-hospitalization among COPD patients. " It is a process that happens with a patient; it is not something the coach does to a patient,†says that study's lead author.